Exploring the interface between metallo-proteinase activity and growth factor and cytokine bioavailability

Cytokine and Growth Factor Reviews

Volumn 13, Issue 3, 2002, Pages 277-287

  Fowlkes, John L ^a   Winkler, Margaret K ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Adamalysins; Cytokine; Growth factor; Matrix metallo proteinase; Metzincin

Indexed keywords

ADAMALYSIN; CYTOKINE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; PAPPALYSIN; PROTEINASE; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADAM PROTEIN; GROWTH PROMOTOR; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ARTICLE; BIOAVAILABILITY; CELL DIFFERENTIATION; CELL GROWTH; CELL MOTILITY; CYTOKINE RELEASE; ENZYME ACTIVITY; EXTRACELLULAR SPACE; HUMAN; MORPHOGENESIS; NONHUMAN; ANIMAL; BIOLOGICAL MODEL; METABOLISM; REVIEW;

ADAM PROTEINS; ANIMALS; CYTOKINES; EPIDERMAL GROWTH FACTOR; GROWTH SUBSTANCES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; METALLOENDOPEPTIDASES; MODELS, BIOLOGICAL; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035992479     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(02)00005-9     Document Type: Review

References (79)

1. Collagenolytic activity in amphibian tissues: A tissue culture assay
2. How matrix metallo-proteinases regulate cell behavior
3. Matrix metallo-proteinases: Effectors of development and normal physiology
4. ECM and cell surface proteolysis: Regulating cellular ecology
5. Structural features of a superfamily of zinc-endopeptidases: The metzincins
6. Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): Classification as a metzincin
7. Matrix metallo-proteinases in tumor invasion and metastasis
8. Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metallo-proteinase inhibitor TIMP-1
9. Impaired endochondrial ossification and angiogenesis in mice deficient in membrane-type matrix metallo-proteinase I
10. Adamalysins: A family of metzincins including TNF-alpha converting enzyme (TACE)
11. Induction of cell migration by matrix metallo-protease-2 cleavage of laminin-5
12. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
13. The metallo-proteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis
14. 1-Proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase
15. Extrinsic regulators of epithelial tumor progression: Metallo-proteinases
16. Matrix metallo-proteinases
17. Tissue inhibitors of metallo-proteinases: Evolution, structure and function
18. Remarkable roles of proteolysis on and beyond the cell surface
19. A metallo-proteinase disintegrin that releases tumor-necrosis factor-a from cells
20. ADAMs: Focus on the protease domain
21. ADAM family proteins in the immune system
22. The ADAM gene family: Surface proteins with adhesion and protease activity
23. Growth factors in the extracellular matrix
24. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors
25. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung
26. Role of insulin-like growth factor-binding proteins in controlling IGF actions
27. The TNF and TNF receptor superfamilies: Integrating mammalian biology
28. Membrane protein secretases
29. TGF-β signaling in cancer - A double-edged sword
30. Mechanism of activation of latent recombinant transforming growth factor-beta 1 by plasmin
31. Thrombospondin-1 is a major activator of TGF-beta1 in vivo
32. The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis
33. 1 release
34. Cell surface-localized matrix metallo-proteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis
35. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles
36. N-3,4-dimethoxycinnamoyl-anthranilic acid (tranilast) inhibits transforming growth factor-β release and reduces migration and invasiveness of human malignant glioma cells
37. Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metallo-proteinase inhibitor, Batimastat, during acute lung injury in mice
38. 1
39. Matrix metallo-proteinases: Multifunctional contributors to tumor progression
40. Cloning of a disintegrin metallo-proteinase that processes precursor tumour-necrosis factor-alpha
41. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3
42. TACE other ADAM proteases as targets for drug discovery
43. An essential role for ectodomain shedding in mammalian development
44. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme
45. Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis
46. Impaired lung branching morphogenesis in the absence of functional EGF receptor
47. Membrane-type 4 matrix metalloproteinase (MMP-17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP-2
48. Matrix metallo-proteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption
49. Heparin-binding-EGF-like growth factor (reviews on cancer)
50. Matrix metallo-proteinase-3 releases active heparin-binding-EGF-like growth factor by cleavage at a specific juxtamembrane site
51. A metallo-protease-disintegrin, MDC-9/meltrin-gamma/ADAM-9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding-EGF-like growth factor
52. Insulin-like growth factors and their binding proteins: Biological actions
53. Insulin-like growth factor I receptor signaling-overlapping or redundant pathways?
54. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
55. MMPs are IGFBP-degrading proteinases: Implications for cell proliferation and tissue growth
56. Matrix metallo-proteinases as insulin-like growth factor-binding protein-degrading proteinases
57. Matrix metallo-proteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures
58. Insulin-like growth factor-binding protein proteolysis: An emerging paradigm in insulin-like growth factor physiology
59. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout routine osteoblast differentiation
60. Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells
61. Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3
62. The matrix metallo-proteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells
63. Proteolysis of insulin-like growth factor-binding protein-3 during rat pregnancy: A role for matrix metallo-proteinases
64. Proteolysis of insulin-like growth factor-binding protein-3 in serum from pregnant, non-pregnant and fetal rats by matrix metallo-proteinases and serine-proteases
65. ADAM-12: A disintegrin metallo-protease, interacts with insulin-like growth factor-binding protein-3
66. ADAM-12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3
67. Proteolysis of insulin-like growth factor-binding proteins by a novel 50-kilodalton metallo-proteinase in human pregnancy serum
68. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts
69. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A
70. Pregnancy-Associated plasma protein-A (PAPP-A) in ovine, bovine, porcine, and equine ovarian follicles: Involvement in IGF-binding protein-4 proteolytic degradation and mRNA expression during follicular development
71. Pregnancy-associated plasma protein-α is the insulin-like growth factor-binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum
72. Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro
73. Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase
74. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor
75. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes
76. IGF-I receptor signalling in transformation and differentiation
77. Growth factors, cytokines, and renal fibrosis during the course of diabetic nephropathy
78. Gelatinase B functions as regulator and effector in leukocyte biology
79. Matrix metallo-proteinase-9 triggers the angiogenic switch during carcinogenesis